Loading organizations...
BNH Investment operates as a venture capital firm managing specialized funds. The firm primarily allocates capital to high-potential companies within the bio and healthcare industries. Through strategic investments and active portfolio management, BNH cultivates innovation and delivers substantial returns for its limited partners from these targeted markets.
Myeong Hwan Kim co-founded BNH Investment LLC in 2015, serving as CEO and General Partner. The firm's establishment was rooted in recognizing significant opportunities within the bio and healthcare sectors. This foundational insight has guided BNH's investment thesis, leading to the successful management of multiple specialized funds.
BNH Investment serves limited partners aiming for exposure to transformative advancements in bio and healthcare. The firm's mission focuses on deploying capital into pioneering companies addressing critical challenges and driving scientific progress. Their long-term vision is to foster an ecosystem of innovative ventures, delivering financial growth and meaningful impact.
BNH Investment has 6 tracked investments across 5 companies. The latest tracked deal is $9.9M Series B in LabInCube in March 2026.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Mar 18, 2026 | LabInCube | $9.9M Series B | — | — |
| Mar 13, 2026 | MustBio | $23.6M Series C | — | Atinum Investment, Korea Development Bank, Korea Investment Partners, Partners Investment, Premier Partners, Shinhan Capital, Wonik Investment Partners |
| Apr 2, 2024 | LabInCube | $4.0M Series A | — | Korea Investment Partners |
| Mar 26, 2024 | AITRICS INC. | $20.2M Series B | BNH Investment, BSK Investment, Premier Partners | Boneum Investment, DS Investment & Securities, HAN River Partners, HB Investment, Shinyoung Securities, Ulmus Investment |
| Nov 30, 2023 | Novorex | $8.9M Series A | BNH Investment, Company K Partners, UTC Investment, Woori Venture Partners | AON Investment, Hana Ventures, KB Investment, Quad Investment Management, Technology Assurance Fund |
| Aug 6, 2021 | Aardvark | $29.0M Series B | Sorrento Therapeutics | Foundation For Prader Willi Research, Korea Omega Investment, Premier Partners, Vickers Venture Partners |
